196 related articles for article (PubMed ID: 37311281)
41. Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy.
Sivashankari PR; Prabaharan M
Curr Cancer Drug Targets; 2016; 16(6):522-35. PubMed ID: 26632433
[TBL] [Abstract][Full Text] [Related]
42. Anti-lung Cancer Marine Compounds: A Review.
Miri MR; Zare A; Saberzadeh J; Baghban N; Nabipour I; Tamadon A
Ther Innov Regul Sci; 2022 Mar; 56(2):191-205. PubMed ID: 35025082
[TBL] [Abstract][Full Text] [Related]
43. Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer.
Rohondia SO; Ahmed ZSO; Dou QP
Curr Cancer Drug Targets; 2020; 20(6):392-409. PubMed ID: 32101123
[TBL] [Abstract][Full Text] [Related]
44. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification.
Xie M; Liu D; Yang Y
Open Biol; 2020 Jul; 10(7):200004. PubMed ID: 32692959
[TBL] [Abstract][Full Text] [Related]
45. Biomimetic Peptides for the Treatment of Cancer.
Mine Y; Munir H; Nakanishi Y; Sugiyama D
Anticancer Res; 2016 Jul; 36(7):3565-70. PubMed ID: 27354624
[TBL] [Abstract][Full Text] [Related]
46. Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer.
Bearz A; Cecco S; Francescon S; Re FL; Corona G; Baldo P
Recent Pat Anticancer Drug Discov; 2019; 14(3):242-257. PubMed ID: 31362665
[TBL] [Abstract][Full Text] [Related]
47. In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases.
Tasdemiroglu Y; Gourdie RG; He JQ
Eur J Pharmacol; 2022 Oct; 932():175192. PubMed ID: 35981605
[TBL] [Abstract][Full Text] [Related]
48. An Anti-Cancer Peptide LVTX-8 Inhibits the Proliferation and Migration of Lung Tumor Cells by Regulating Causal Genes' Expression in p53-Related Pathways.
Zhang P; Yan Y; Wang J; Dong X; Zhang G; Zeng Y; Liu Z
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32498425
[TBL] [Abstract][Full Text] [Related]
49. Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection.
Ruiz-Ceja KA; Chirino YI
Biomed Pharmacother; 2017 Jun; 90():24-37. PubMed ID: 28340378
[TBL] [Abstract][Full Text] [Related]
50. Anticancer potential of bioactive peptides from animal sources (Review).
Wang L; Dong C; Li X; Han W; Su X
Oncol Rep; 2017 Aug; 38(2):637-651. PubMed ID: 28677775
[TBL] [Abstract][Full Text] [Related]
51. A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.
Chang DK; Lin CT; Wu CH; Wu HC
PLoS One; 2009; 4(1):e4171. PubMed ID: 19137069
[TBL] [Abstract][Full Text] [Related]
52. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
[TBL] [Abstract][Full Text] [Related]
53. Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside.
Jafari A; Babajani A; Sarrami Forooshani R; Yazdani M; Rezaei-Tavirani M
Front Oncol; 2022; 12():819563. PubMed ID: 35280755
[TBL] [Abstract][Full Text] [Related]
54. [Peptides: a new class of anticancer drugs].
Smolarczyk R; Cichoń T; Szala S
Postepy Hig Med Dosw (Online); 2009 Jul; 63():360-8. PubMed ID: 19644153
[TBL] [Abstract][Full Text] [Related]
55. Chemoradiotherapy of non-small cell lung cancer.
Jassem J
Expert Rev Anticancer Ther; 2002 Aug; 2(4):402-7. PubMed ID: 12647983
[TBL] [Abstract][Full Text] [Related]
56. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
57. [Host defense peptides and peptidomimetics as new weapons for cancer treatment].
Lapis K
Magy Onkol; 2010 Mar; 54(1):47-58. PubMed ID: 20350868
[TBL] [Abstract][Full Text] [Related]
58. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
59. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
60. Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells.
Khine HEE; Ecoy GAU; Roytrakul S; Phaonakrop N; Pornputtapong N; Prompetchara E; Chanvorachote P; Chaotham C
Sci Rep; 2021 Feb; 11(1):4060. PubMed ID: 33603033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
